DLBCL: Managing Toxicities of CAR T-Cell Therapy – OncLive
OncLive |
DLBCL: Managing Toxicities of CAR T-Cell Therapy
OncLive Transcript: Stephen J. Schuster, MD: There are 2 unique toxicities of CAR T cells that physicians and oncologists will learn about as they begin to manage patients: cytokine release syndrome and neurotoxicity. Cytokine release syndrome is the result of … |
